Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension

G. Calcaianu, A. Schuller, A. Chaouat, M. Canuet, R. Kessler (Strasbourg, Nancy, France)

Source: International Congress 2014 – Pulmonary hypertension in lung disease
Session: Pulmonary hypertension in lung disease
Session type: Thematic Poster Session
Number: 2334
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Calcaianu, A. Schuller, A. Chaouat, M. Canuet, R. Kessler (Strasbourg, Nancy, France). Specific pulmonary arterial hypertension therapy in COPD patients with severe pulmonary hypertension. Eur Respir J 2014; 44: Suppl. 58, 2334

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Long-term screening for pulmonary hypertension after pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014


Characteristics of patients with pulmonary hypertension in end stage renal disease
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Unique characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease compared to the rest of pulmonary arterial hypertension subgroups
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Nebivolol and pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014

Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Cerebral tissue oxygenation in arterial and thromboembolic pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Exercise-induced pulmonary hypertension in patients with systemic sclerosis: Pilot-study
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Female pulmonary arterial hypertension is associated with decreased microRNA96 expression
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014

Beta-blocker therapy nor hyperoxic breathing lowers ventilatory drive in pulmonary arterial hypertension patients
Source: International Congress 2014 – Pulmonary hypertension: right ventricular function, exercise and gas exchange
Year: 2014


Sildenafil improves heart rate variability, pulmonary hemodynamics and functional status in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014

The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014

Immune signatures in pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014

Effects of riociguat in patients with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) following pulmonary endarterectomy (PEA)
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014



CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary arterial hypertension – A single-centre experience
Source: International Congress 2014 – Pulmonary hypertension: clinical management
Year: 2014


Effect of pulmonary hemodynamics on the prognosis of patients with emphysematous COPD after LVRS
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014